Pediatric Brain Tumors | CHOP Research Institute

Pediatric Brain Tumors

Published on
Jul 5, 2024
CHOP experts look to improve young concussion patients’ outcomes and develop an image-based classification tool for retinopathy of prematurity.
Published on
Nov 11, 2022
This week’s research news roundup includes accolades for our scientists and the spaces they work in.
Published on
May 23, 2022
Neuro-oncologist Jessica Foster MD, is investigating chimeric antigen receptor (CAR) T-cell therapy for brain tumors.
Published on
Nov 2, 2021
Whole genome sequencing for thousands of brain tumor samples will give the D³b team insight into devastating pediatric cancers.
Published on
Aug 20, 2021
This week in the news, we share findings on Fontan circulation side effects, pediatric brain tumor survivorship, gene therapy, and more.
Published on
Dec 4, 2020
This week’s roundup features CHOP’s participation in a multi-institutional MIS-C research study — the first to provide long-term outcome data.
Published on
Feb 10, 2020
New research utilizes eye-tracking technology to study visual social attention in pediatric brain tumor survivors.
Published on
Jul 12, 2019
Many parents working in private sector are turning to Medicaid and CHIP for children’s healthcare coverage. This story and more In the News.

Dr. Storm directs CHOP's translational brain tumor laboratory and maintains a research program focusing on cell signaling cascades in pediatric brain tumors. The goal of this research is to understand and identify potential targets that can be developed into clinical therapy. His team is also leading collaborative efforts to de-silo research by engaging in open source platforms and cloud-based sharing.

storm [at]
Published on
May 24, 2018
Guest blogger, Adam Resnick, PhD, illustrates the phenomenal growth of CHOP-led consortia to collaborate and share data to promote pediatric brain tumor research.